US 12,220,460 B2
Immunity-inducing agent and pharmaceutical composition containing same
Shinichi Mochizuki, Fukuoka (JP); Kazuo Sakurai, Fukuoka (JP); and Hiromi Morishita, Fukuoka (JP)
Assigned to The University of Kitakyushu, Kitakyushu (JP)
Filed by The University of Kitakyushu, Kitakyushu (JP)
Filed on Sep. 8, 2023, as Appl. No. 18/463,609.
Application 18/463,609 is a division of application No. 16/498,374, granted, now 11,793,874, previously published as PCT/JP2018/011201, filed on Mar. 20, 2018.
Claims priority of application No. 2017-068276 (JP), filed on Mar. 30, 2017.
Prior Publication US 2024/0075132 A1, Mar. 7, 2024
Int. Cl. A61K 39/385 (2006.01); A61K 39/39 (2006.01); A61K 47/56 (2017.01)
CPC A61K 39/39 (2013.01) [A61K 47/56 (2017.08)] 14 Claims
OG exemplary drawing
 
1. An immunity-inducing agent comprising, as an active component, a polynucleotide/peptide conjugate in which an antigenic peptide is covalently bound to a single-stranded polynucleotide or polynucleotide derivative, wherein the polynucleotide or polynucleotide derivative is a polydeoxycytidylic acid, a polydeoxythymidylic acid or a polydeoxyguanylic acid, and wherein the polynucleotide or polynucleotide derivative is not complexed with β-1,3-glucan.